Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

BrePco Biopharma Limited today announced that the UK Medicines and Healthcare products Regulatory Agency issued a grant of a ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

The global vitamin K2 market is rapidly growing due to its role in preventing cardiovascular diseases and supporting bone ...

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

Niswonger Children’s Hospital Radiothon concluded by committing more than $600,000 toward a new neonatal transport unit to serve children in the Appalachian Highlands, surpassing the fundraiser’s orig ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for a ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and can lead to a domino effect of life-saving procedures.